June 2nd Power Hour with Shahnam Sharareh

Date: Jun 2, 2011 18:30:00 to 20:00
Location: Sahara Restaurant, 165 Easton Avenue, New Brunswick, NJ 08901
Ticket Cost: Free! ($5 suggested donation to cover the cost of food)

Event Details

CAMP NJ is proud to host Shahnam Sharareh at its next Power Hour in New Brunswick, NJ. Shahnam is an attorney at Fox Rothschild, and his extensive pharmaceutical background lends itself to a wealth of knowledge in the drug development process. Shahnam will focus the discussion on intellectual property, specifically what it entails and why it's important for small businesses to protect it. Join us for some light appetizers and an evening of great networking--see you there!

Shahnam's bio:

Shahnam is an attorney with the law firm of Fox Rothschild. His practice is concentrated in :
  • U.S. and international intellectual property
  • antitrust
  • technology transfer
  • FDA regulatory issues
His experience includes performing a variety of intellectual property activities, including prosecuting patent applications in the fields of:
  • chemistry
  • pharmacology
  • biotechnology
  • cosmetic, pharmaceutical, and diagnostic compounds and compositions, and their methods of use
He also advise clients on related regulatory activities during the drug development phase. Shahnam earned his Bachelor of pharmacy from University of New Mexico, and his Doctor of Pharmacy from University of Illinois at Chicago, and his Law degree from University of Maryland at Baltimore. He has also completed and pharmacy practice residency at Washington Hospital Center in DC and is also a Certified Regulatory Affairs Professional which is the only certification for regulatory professionals in the healthcare product sector recognized in all parts of the world.
Before Fox Rothschild, Shahnam was a Patent Examiner with the U.S. Patent and Trademark Office, where he managed an extensive portfolio including pharmaceutical and diagnostic compounds and compositions. He evaluated U.S. and international patent applications for novelty, obviousness, enablement, written description, and definiteness.
Prior to entering the legal field, Shahnam was a research associate with Kendle International, where he monitored FDA-required regulatory and clinical data during the Celecoxib clinical trials.
 
He is also serves on the Board of a local non-profit organizations, CONTACT of MERCER county which provides 24/7 suicide prevention hotline for local community.
See All Events